Cantor Lifts Target on Hologic (HOLX) to $21; Q1 Solid, Buy Challenges Remain
Tweet Send to a Friend
Cantor Fitzgerald is lifting its price target on Hologic, Inc. (Nasdaq: HOLX) from $19 up to $21, but maintains a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
